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Abstract

The double-stranded RNA (dsRNA) activated protein kinase, PKR, is one of the
several enzymes induced by interferons and a key molecule mediating the antiviral
effects of interferons. PKR contain an N-terminal, double-stranded RNA binding domain
(dsRBD), which has two tandem copies of the motifs (dsRBM I and dsRBM II). Upon
binding to viral dsRNA, PKR is activated via autophosphorylation. Activated PKR has
several substrates; one of the examples is eukaryotic translation initiation factor 2
(eIF2a). The phosphorylation of eIF2a leads to the termination of cell growth by
inhibiting protein synthesis in response to viral infection. The objective of this project
was to characterize the dsRBM I and define the dsRNA binding using biophysical
methods.

First, the dsRBM I gene was cloned from a pET-28b to a pET-11a

expression plasmid. N-terminal poly-histidine tags on pET-28b are for affinity
purification; however, these tags can alter the structure and function of proteins, thus the
gene of dsRBM I was transferred into the plasmid without tags (pET-11a) and expressed
as a native protein. The dsRBM I was transformed into and expressed by Rosetta
DE3plyS expression cells. Purification was done by FPLC using a Sepharose IEX ion
exchange followed by Heparin affinity column; yielding pure protein was assayed by
PAGE.
Analytical Ultracentrifugation, Sedimentation Velocity, was used to characterize
free solution association state and hydrodynamic properties of the protein. The slight
decrease in S-value with concentration is due to the hydrodynamic non-ideality. No self
association was observed. The obtained molecule weight was 10,079 Da. The calculated
sedimentation constant at zero concentration at 20°C in water was 1.23 and its friction
coefficient was 3.575 × 10-8. The frictional ratio of sphere and dsRBM I became 1.30.
Therefore, dsRBM I must be non-globular and more asymmetric shape.
Isolated dsRBM I exhibits the same tertiary fold as compared to context in the full
domain but it exhibited weaker binding affinity than full domain to a 20 bp dsRNA.
However, when the conditions allowed for its saturation, dsRBM I to 20 bp dsRNA has
similar stoichiometry as full dsRBD.Introduction

I.1 Double-Stranded RNA binding protein
Molecule recognition of double-stranded RNA (dsRNA) has a critical role in
numerous cell regulatory processes, such as trafficking, editing, maturating of cellular
RNA, interferon antiviral response, and RNA interference. Although proteins involved in
the molecular recognition of dsRNA have varying functions and can identify their
specific dsRNA targets, they have structural similarities. Large and diverse classes of
proteins that bind to dsRNA do so by utilizing a 65-75 amino acid dsRNA binding motif
(dsRBM) and all of the dsRNA binding protein family members possess at least one copy
of the dsRBM with which to identify dsRNA (Fierro-Monti et al., 2000). These proteins
can have multiple copies of the dsRBMs, which compose a dsRNA-binding domain
(dsRBD). The study of protein-dsRNA binding may be helpful to find the way to control
the functions of those dsRNA-binding proteins. However, a fundamental understanding
of the protein-dsRNA recognition and binding selectivity is currently being established.
There are at least nine families of functionally diverse proteins containing one or
more dsRBMs and currently the list of homologous sequences is over 100 that are present
in proteins from different organisms, including viruses, bacteria and lower and higher
eukaryotes.

I.2 RNA-activated protein kinase, PKR
Interferons are cellular proteins with antiviral activity secreted by vertebrate cells
in response to virus infection or antigen stimulation. Healthy cells do not synthesize
detectable amounts of interferon and formation of interferons must be induced.
Interferons are produced by virus-infected cells to protect uninfected cells against
infection or to decrease the chance that virus infection will be able to initiate a productive
multiplication cycle in them. Interferons can interact with non-infected cells and induce
in these cells an antiviral state; therefore, replication of virus is blocked in interferontreated cells (Joklik et al., 1988).
The dsRNA activated protein kinase (PKR) is one of several enzymes induced by
interferons and is one of the key molecules mediating the antiviral effects of interferons
(Stark et al., 1998). It plays a central role in the biological activity of interferons, which
are widely employed in the treatment of cancer and viral infections. The importance of
this antiviral pathway is highlighted by the diverse mechanisms that viruses have evolved
to combat PKR (Gale et al., 1998). A high proportion (60 ~ 80 %) of hepatitis C patients
fails to respond to or suffers relapses after interferon therapy. The cause of hepatitis C
resistance to interferon has been identified as a viral protein that directly inhibits PKR.
Interferon therapy is also not successful against HIV because this virus uses multiple
mechanisms to counteract PKR. Thus, the therapeutic effectiveness of interferons is
compromised by disease specific resistance and by side effects, including fever, mood
disorders, and fatigue. Interferon activates a large number of signaling pathways;
therefore, selective activation of one therapeutically relevant component, such as PKR,
may lead to reduced side effects and improved clinical outcomes. Direct regulation of

PKR activity may provide an effective way of inducing therapeutic apoptosis in infected
or malignant cells. A detailed understanding of the mechanism of PKR activation is
required to effectively target this enzyme for clinical intervention against cancer and viral
infections.
PKR is synthesized in an inactive state, but upon binding to dsRNA it becomes
autophosphorylated and capable of phosphorylating other proteins. There is a new
discovery in Cole’s lab that PKR can become autophosphorylated in the absence of
dsRNA; the reaction is induced by self-association (Lemaire et al., 2005). Although selfassociation of unphosphorylated PKR is weak, this discovery may open new approaches
to investigate the PKR activation process. Phosphorylated PKR can phosphorylate
eukaryotic initiation factor 2 (eIF2 ), thus blocks protein synthesis. Therefore,
production of dsRNA during viral infection leads to PKR activation and inhibition of
viral protein synthesis. The dsRBMs of PKR are similar to a molecular switch that
regulates its kinase activity (Carlson et al., 2003). However, several viruses have
evolved RNAs that can bind to PKR and block activation of the kinase, in doing so they
can avoid the cell’s endogenous antiviral response. As a result, PKR has two classes of
RNA ligands; kinase activating and kinase inhibiting (Conrad et al., 2001). Despite
extensive investigations, the features that distinguish RNAs that activate from those that
fail to activate remain poorly understood. Development of structure-function
relationships of RNA activators will provide a rational basis for the design of drugs to
specifically modulate the function of PKR. In addition, studies of dsRNA-independent
activation may lead to methods to circumvent inhibition of PKR by kinase inhibiting
RNA ligands.

Human PKR is a large protein consisting of 551 amino acids. The N-terminal
region is the dsRNA binding domain and the C-terminal region is the kinase domain
(Figure 1). The RNA binding domain contains two copies of a 90 amino acid dsRBM
labeled dsRBM I and dsRBM II. Studies with truncated PKR proteins show that dsRBM
I (p10a) is capable of independently binding to dsRNA (Tian et al., 2001). The second
motif (p10b) binds RNA much more weakly.

Figure 1 Structure of PKR (Tian et al., 2000)

I.3. Why study dsRBM I binding?
A fundamental understanding of the protein-dsRNA recognition and binding
selectivity is currently being established and the study of protein-dsRNA binding is
helpful to find the way to control the functions of those dsRNA-binding proteins. The
selective activation of signaling pathways may lead to improvement in clinical
application against cancer and viral infections. Direct regulation of PKR activity may
provide an effective way of inducing therapeutic apoptosis in infected or malignant cells.
A detailed understanding of the mechanism of PKR activation is required to effectively

target this enzyme. The dsRBMs play a key role in PKR function and regulation,
although their exact role in PKR activation is not clear yet.
The study of an isolated dsRBM I is important for promoting better understanding
of PKR-RNA binding mechanism. In Cole’s lab, studies of the dsRBD-RNA interaction
have been pursued earlier (Ucci et al., 2004). The dsRBD binds to dsRNA as one object,
thus the role of each of the two dsRBMs in binding cannot be seen. Studies of the
interaction of isolated dsRBM I with dsRNA would give a more detailed understanding.
Also, the stoichiometry for binding of the dsRBD to a 20 bp dsRNA does not agree with
published binding models, which has lead to a new overlapping lattice model of dsRBDRNA binding (Ucci et al., 2004). In order to test this model, characterization of the
simpler dsRBM I-dsRNA interaction is necessary.

I.4 Structural Studies with Affinity Cleavage
In order to clarify the differences between activating and inhibiting PKR-RNA
complex, affinity cleavage data have been generated to define the contribution of each of
the dsRBMs upon binding dsRNA. Mutations are introduced to control PKR binding
strength to dsRNA in each dsRBM by altering its amino acid side chains. The affinity
cleavage technique is originally developed as a tool to study DNA binding proteins. The
principle of the method is to elucidate specific structural elements using the cleavage
pattern of altered point mutations. The point mutations are designed to change the
strength of protein-dsRNA bindings. It is widely used to define structural features of
complexes between proteins and nucleic acids. In a typical experiment, a hydroxyl
radical generator, Fe EDTA, is site-specifically and covalently attached to a nucleic acid

binding protein, then the hydroxyl radicals are generated which locally cleave the nucleic
acid. Finally, this cleavage pattern is mapped onto the dsRNA sequence. The resulting
data map is used to define structural elements that determine binding selectivity, such as
the number of binding sites present on the nucleic acid, the location of the binding sites,
the orientation of the protein on the nucleic acid, and cooperativity of multiple protein
motifs.

I.5 Two binding mechanisms of dsRBMs
In Beal’s laboratory, the dsRBD was modified with cysteine residue that can
conjugate with bromoacetyl-Fe EDTA at three positions, which are D38C and E29C of
dsRBM I and Q120C of dsRBM II (Spanggord et al., 2002). The affinity cleavage data
were used to create models for the complexes formed by juxtaposing the modified site of
the protein with the cleaved nucleotides in the RNA. The inhibiting RNA is derived from
the Epstein Barr Virus (EBER 1) and the activating RNA is derived from HIV TAR.
With multiple modifications on a single motif, it is possible to establish the orientation
and approximate position.
In case of an inhibiting RNA, only dsRBM I binds to the dsRNA at two distinct
sites but dsRBM II does not bind to the dsRNA at all. The inhibiting RNA only interacts
with the dsRBM I, allowing the dsRBM II to inhibit the kinase domain of PKR (Vuyisich
et al., 2002). It seems as if the viral RNA is designed to sequester two equivalents of
PKR in an inactive state to support viral proliferation.
In contrast, in the case of an activating RNA, both dsRBM I and dsRBM II bind
to the distinctive sites on the same RNA ligand simultaneously (Figure 2). It appears that

simultaneous binding to TAR relieves the inhibitory contacts to the kinase domain and
supports activation of protein. These data agree with the observations that longer duplex
regions are required for PKR activation, although only 16-18 bp is sufficient to support
binding of one dsRBM of PKR.

Figure 2: A. Crystal structure of the X. laevis RNA binding protein A (Xlrbpa) bound to dsRNA. Three regions
on the RNA contacted by dsRBM (Ryter and Schultz, 1998). B. NMR structure of Staufen’s third dsRBM
bound to a stem-loop RNA (Ramos et al., 2000). C. Sequence alignment of numerous dsRBMs. D. Model of
HIV TAR RNA binding with PKR (Spanggord and Beal et al., 2003)

The cleavage pattern with kinase – activating RNA supports two binding sites for
dsRBM I and one binding site for dsRBM II. The cleavage pattern derived from dsRBM
II overlapped with one of the dsRBM I sites, so it seems both motifs do not bind to this
site simultaneously. However, the second binding site for dsRBM I could be occupied
with simultaneous binding by dsRBM II.
In order to test the dependence of dsRBM I on dsRBM II for binding, a K150A
mutation in dsRBM II was introduced to reduce the affinity of dsRBM II. The K150A
mutation has been shown to decrease the binding affinity of PKR for RNA (Patel et al.,
1996). The mutant protein was labeled with bromoacetyl-Fe EDTA at dsRBM I. The

two binding sites of dsRBM I are at the 5’-stem loop and 3’-stem loop. The 5’-stem
binds to only dsRBM I and 3’-stem may bind to either dsRBM I or dsRBM II. The
modified protein shows decreased cleavage at 5’-stem loop. This indicates that the
binding of dsRBM I to the 5’-stem loop site is dependent on dsRBM II binding
(Spanggord et al., 2002). Decreased affinity of dsRBM II to RNA leads also to an
increased efficiency of cleavage at the 3’-stem by dsRBM I. For the further investigation
of simultaneous binding, RNA concentration was reduced so that only the 3’-stem
binding site was occupied. As a result, dsRBM I bound the RNA but dsRBM II did not.
Consequently, there are two binding mechanisms observed from above data; the
cooperative binding of both motifs in one complex, and independent binding of dsRBM I
in a separate protein-RNA complex.
These experiments also address the intrinsic binding selectivity. These dsRBMs
may not exhibit strict sequence specificity; however, they clearly have the ability to
distinguish distinct structural features of RNA (Carlson et al., 2003). The dsRBMs show
the ability to bind to known RNA ligands in a site-selective manner. Additionally, the
differences of selectivity for binding between two motifs are observed. The affinity
cleavage data suggest that dsRBMs do not bind to kinase-inhibiting RNA simultaneously
and have two distinct binding sites only for dsRBM I but not for dsRBM II. In contrast,
the data suggest that both dsRBM I and dsRBM II can bind to kinase-activating RNA
simultaneously.

I-6 Sedimentation of Particles in a Gravitational Field
Sedimentation velocity is a useful tool to understand some of the physical
characteristics of proteins. Initially uniform protein solution is placed in the cell and very
high angular velocity is used to cause rapid sedimentation of the protein toward the cell
bottom. This rapid sedimentation produces a depleted region of protein near the
meniscus and the formation of sharp boundary between the depleted region and the
uniformly sedimenting protein region. The actual velocity of individual protein molecule
cannot be measured; however, the rate of movement of the boundary can be measured.
The sedimentation coefficient, which is directly related to the mass of the particle and
inversely to the friction coefficient, can be found in this experiment. When a protein
(solute) is suspended in a buffer (solvent) and high angular velocity is applied, three
forces act on the protein;
Friction force (F = -fu)
Buoyant force (F = -mo T2r = -T2rmvD)
Sedimenting force (F = mT2r)

There is a sedimenting force (gravitational force), F, which is proportional to the
mass of the particle and the acceleration. The acceleration is determined by the distance
of the particle from the axis of rotation, r, and the square of the angular velocity, T.
T2r) / NA
F = mT
T2r = (MT
where m is the mass (g) of a single particle, M is the molar weight of the solute (g/mol)
and NA is Avogadro’s number.

There is also a buoyant force (Fb), which can be explained by Archimedes’
principle. And it is equal to the weight of fluid displaced:
F = - mo T2r
where mo is the mass of fluid displaced by the particle:
mo = m
v D = (MvD
D) / NA
where v (mL/g) is the partial specificvolume of the protein and D (g/mL) is the density of
the buffer. When the density of the protein is greater than that of the buffer, the protein
will begin to sediment. The protein begins to move along a radial path toward the cell
bottom. As the protein moves toward the cell bottom, its velocity, u, will increase
because its radial distance increases. Because protein is moving through a viscous fluid,
it will have a frictional force that is proportional to the velocity;
F = -fu
where f is the friction coefficient, which depends on the shape and size of the protein.
Asymmetric or elongated proteins have more frictional drag than globular, smooth ones.
The equations

and

must have negative signs because these two forces act in the

opposite direction from sedimentation force.
When the three forces come into balance:
Friction force + Buoyant force + Sedimenting force = 0
DT2r / NA) – fu = 0
(MT
T2r / NA) – (MvD
{MT
T2r (1-vD
D) / NA} – fu = 0
When the terms that relate to the particle and the terms that relate to the
experimental conditions combine:
{M(1-vD
D)T
T2r} / NAf = u / T2r = S

The velocity of the protein per unit gravitational acceleration (u / T2r) is called the
sedimentation coefficient, S, and it is a physical property of the protein. It is proportional
to the buoyant effective molar weight of the protein and it is inversely proportional to the
friction coefficient. If the proteins in the buffer have different molecular weights, or
different shapes and sizes, they move with different velocities under the application of the
same centrifugal field, therefore, each protein will have their own unique sedimentation
coefficients. The unit of the sedimentation coefficient is seconds.
Measurement of the rate of sedimenting boundary broadening can be used for
determination of the diffusion coefficient, D, which is proportional to effective size of the
proteins:
D = RT / NAf
where R is the gas constant and T is the absolute temperature. The ratio of the
sedimentation coefficient to the diffusion coefficient gives the molecular weight:
M = S°RT / D°(1-vD)
where M is the molar weight of the solute, v is partial specific volume, and D is the
solvent density. The S° and D°are the values at zero concentration, which are calculated
from several measurements at several different concentrations to remove the effects of
interaction between proteins on their movement. Approximate molecular weights can be
estimated using sedimentation coefficient and diffusion coefficient. The existence of a
single sedimenting boundary indicates homogeneity. On the other hand, the existence of
multiple boundaries is evidence for multiple sedimenting species.
In cases where a protein undergoes association reactions, the molecular weight of
the protein increases. Therefore, the sedimentation coefficient will increase with

increasing protein concentration. The sedimentation pattern will become complex and
will depend on the rate of association and dissociation reactions. If the rates of
interconversion are slow compared to the time of the sedimentation experiment, each
species can give rise to a separate boundary. In this case, the molecular weights, sizes
and shapes of the various oligomers can be analyzed.
In order to determine a molecule weight using the sedimentation coefficient,
accurate estimation of the diffusion coefficient is necessary. The diffusion coefficient
also provides information useful about the size and shape of the solute particles. The
frictional coefficient is proportional to the radius, R, of a spherical particle:
F = 6B
B0 R

11

The friction coefficient increases as the shape diverge from sphere. For
ellipsoids, f increases with the axial ratio, and increases more for elongated ellipsoids
than for flattened ellipsoids. The frictional ratio is useful in estimating molecule shape.
The frictional ratio is a comparison of the measured friction coefficient, f, with a
calculated friction coefficient of a smooth sphere model, fo, assuming that the smooth
sphere has the same weight and specific volume. The frictional ratio, f / fo, has been
found to be near 1.2 for globular proteins, and increases with asymmetry.
In sedimentation equilibrium, a small volume of an initially uniform solution is
centrifuged at lower angular velocity. As a protein begins to sediment towards the cell
bottom, the concentration at the bottom increases. The force of diffusion opposes to the
force of sedimentation. After an appropriate period of time, the two forces approach to
equilibrium. The concentration of the protein increases exponentially towards the cell

bottom. When it reaches to equilibrium, there is no net movement of molecules, because
the diffusion force exactly balances sedimentation force everywhere in the cell.
C(r) = Co exp[M(1-v )T
T2/2rT(r2-ro2)]
where M is the solute molar weight (g/mol),

12

is the angular velocity of the rotor, c is the

concentration of the solute (g/L) and r is the radial distance from the axis of the rotation.
The sedimentation equilibrium is the best way for determining the molecular weight of
macromolecule. The radial concentration gradient is determined by the molecular weight
of the protein.
To monitor binding of dsRBM I to dsRNA, various concentrations of protein will
be tested. As the concentration of protein increases, the probability of protein binding to
dsRNA increases. By varying the ratio of protein concentration to dsRNA concentration
up to the saturation point, the stoichiometry of protein and dsRNA can be determined. It
is a measurement of the increase in the dsRNA buoyant mass in presence of saturating
concentration of protein. In order to achieve the stoichiometric binding conditions, the
RNA concentration must be significantly higher than the protein-RNA dissociation
constant.

Materials and Methods

M.1. Cloning the p10a gene in pET-11a plasmid
1-1 Preparation of plasmids
Originally, the dsRBM I gene received from M. B. Mathews was in a pET-28b
expression plasmid. However, the N-terminal poly-histidine tags on pET-28b can alter
the structure and function of proteins, thus the gene of dsRBM I was attempt to transfer
into the pET-11a expression plasmid, which has no tags. The p10a gene was excised
from a pET-28 expression vector using an NdeI restriction site immediately before the
start codon and BamHI restriction site after the stop codon. The double digest was
incubated at 37 °C overnight but no longer than 16 hrs. Samples from the restriction
digestion were desalted and concentrated to approximately 20 µL using a
microconcentrifugal filter device, YM10. Samples were purified on a 1.2%
weight/volume agarose gel. The DNA was extracted from the gel using UltraFree-DA
kit. DNA samples were concentrated to approximately 20 µL using the
microconcentrifugal filter device YM10. The insert was cloned into pET-11a to obtain
pET-11a p10a. The DNA was sequenced afterwards for confirmation.

a. Preparation of pET-28-p10a
A glycerol stock of pET-28, a kanamycin resistant plasmid containing the p10a
gene, was grown in LB medium with 30 µg/mL kanamycin at 37 °C overnight to obtain a

liquid culture. Plasmid DNA was extracted using QIA prep spin Miniprep kit (QIAGEN
Science) and the concentration was determined by UV spectroscopy.

b. Confirmation of p10a gene in pET-28 plasmid by ABI-prism sequencing

b-1) DNA dilution
Sample
P10a
primer

Stock concentration
125.6 (ng/µL)
5 µM (5 pmol/µL)

b-2) Reaction Mixture
pure water
template DNA
T7 primer
Terminator ready reaction mix

Volume taken
10 µL
1 µL

Amount of DNA
1256 ng
5 pmol

1 FL
10 FL (1256ng)
1 FL (5 p mol)
8 FL
20 FL

total
b-3) Thermocycling Program
segment
1
2

cycle
1
40

3

Reaction
melting
melting
annealing
extension
hold

temp(°C)
95
95
50
60
4

time
3 min
30 sec
30 sec
4 min
indefinitely

end
*Mixture was heated in segment 1 for 2 min before adding Big-dye terminator ready reaction mix.

b-4) Ethanol Percipitation of PCR product
Two µL of 3M Sodium acetate (pH 5.2) and 40 µL of cold 95% ethanol (-20 ºC)
were added to the PCR product DNA and let it sit for 30 min. The solution was

centrifuged at 14,000rpm for 10 min at 4 ºC. The pellets were washed twice with 150 µL
of cold 70% ethanol (-20 ºC) and centrifuged at 14,000 rpm for 10 min at 4 ºC. The tubes
were left on the bench overnight to dry.

1-2 Double restriction digestion
PpET-11a
fsdH2O
React 6
DNA
BSA
Nde I
BamH I
Final Volume

Stock concentration

Volume added (µL)

Final amount

10 X
194.6 ng/µL
100X (10mg/mL)
5U/µL
10U/µL

126
20
40
2
8
4
200

1X
7.784 µg
100 µg/mL
40U
40U

-1U of enzyme was required to digest 1 µg of DNA in I hr at 37 °C, hence this represents approximately 5X over
digestion.

PET28-p10a
fsdH2O
React 6
DNA
BSA
Nde I
BamH I
Final Volume (µL)

Stock concentration

Volume added (µL)

Final amount

10 X
243.7 ng/µL
100X (10mg/mL)
5U/µL
10U/µL

411
60
90
6
22
11
600

1X
21.933 µg
100 µg/mL
110U
110U

-1U of enzyme was required to digest 1 µg of DNA in I hr at 37 °C, hence this represents approximately 5X over
digestion.

1-3 Ligation
The following components were mixed well before adding T4 DNA ligase. The
entire mixture was mixed again, spun down and incubated at 16 °C overnight.

components
fsdH2O
5X ligase rxn buffer
PET-11 a digested

P10a insert
T4 DNA ligase
Final Volume (µL)

- control
8
4
0
0
1
20

background
15
4
2
0
1
20

reaction 1
0
4
2
4
1
20

reaction 2
0
4
2
10
1
20

1-4 Transfer p10a gene
The 1.5 µL ligation mixture was transferred into 50 µL NovaBlue competent cells
and 25 µL, 50 µL, and 100 µL of cells were plated on LB plates containing 50 µg/mL
carbenicillin. As a control, 1.5 µL of pET-28 was transferred into 25 µL of NovaBlue
competent cells were plated. The transformed plates were incubated at 37 °C overnight.
The pET-11a-p10a expression vector was transferred into Rosetta (DE3) pLyS
cells for protein expression (Novagen). The transferred gene was confirmed to have no
mutation during this procedure by ABI-Prism sequencing. The overnight cultures of six
colonies were made and glycerol stocks of them were stored at - 80°C.

M.2. Optimizing expression of p10a
2-1 Preparation prior to the testing induction
500 mL of LB broth was prepared in a 2 L flask by adding 12.5 g of solid LB to
mix and was sterilized for 60 min on liquid cycle by autoclaving. After the LB broth was
cooled, chloramphenicol (34 µg/mL) and carbenicillin (50 µg/ml) were added. A 5 ml
starter culture was inoculated with pET-11a-p10a in Rossetta cells and incubated
overnight in the shaker incubator at 37°C at a speed of 250 rpm.

2-2 Induction test
To 500 mL of LB broth in 2 L flask, 3 mL of over night culture was added. Its
OD (absorbance) at 600 nm, A600, was measured immediately to find its baseline. The
starting culture in 2 L flask was placed in shaker incubator at 37°C and the OD was
measured in order to observe the cell growth. When the OD value reached 0.6,
isopropyl- -D-thiogalactopyranoside (IPTG) was added so that the final concentration
was 1 mM. The pre-induced and 1, 2, 3 hour induced samples were stored for later gel
analysis to characterize p10a induction.

2-3 Gel analysis of induction
a. Preparation prior to the experiment
Samples (120 µL) were thawed and transferred into microtubes. The samples
were centrifuged at max speed for 15 min and pellets were resuspended with 120 µL of
pure water. Then Trichloroacetic acid (TCA) was added, so that the final concentration
of TCA would be 10% (30 µL of 50% TCA solution). The solution was centrifuged for
20 min at max speed. In order to remove TCA, 1 mL of acetone was added without
disturbing the pellet then centrifuged for 5 min at max speed. The pellet was dried by
removing excess acetone and exposed to air. The pellets were suspended with 35 µL
pure water and SDS loading buffer was added so that the final concentration was 25%
(12 µL). BME was added, so that the final concentration of BME is 15% (10 µL of
14.2M BME). The solution was vortexed for 30 sec. The solution was heated for 10 min
at 70 °C.

b. Running SDS gel
The samples were loaded onto 12% Polyacrylamide precast gels and
electrophoresed at 200 V for 40 min. After running, the gel was stained with 500 mL
Coomassie Brilliant Blue and heated for 30 sec at high power in a microwave oven.
After 15 min of staining, the gel was destained for 15 min. Then the destain solution was
discarded and water was added, the gel was heated for 30 sec with high power and placed
on the shaker at room temperature for 15 min. After 15 min, water was discarded and
fresh water was added to the gel, heated for 30 sec with high power and set for 15 min
and it was repeated twice.

M.3 Protein purification
3-1 Cell Lysis
For p10a protein purification, cells were resuspended in buffer A (20 mM Bicine,
50 mM NaCl, 1 mM EDTA, 5% Glycerol, 10 mM -mercaptoethanol, pH 8.0)
supplemented with protease inhibitor cocktail (Sigma). Cells were lysed by sonication
for 20 cycles of 30 sec. on ice followed by PEI precipitation by adding 4% PEI solution
to the suspended cell lysate to yield a 0.2% w/v final concentration. The lysate was
centrifuged for 15 min at 20,000 g.
3-2 Column chromatography
The supernatant was applied to an S-Sepharose ion exchange column (Amersham)
equilibrated in buffer A and p10a was eluted using a NaCl gradient from 50 mM to 1 M.
The peak fractions were diluted two-fold with buffer A0 (20 mM Bicine, 1 mM EDTA,

5% Glycerol, 10 mM -mercaptoethanol, pH 8) in order to reduce its salt concentration
and applied to a Heparin Sepharose column (Amersham) equilibrated in buffer A. The
p10a protein was eluted using the same NaCl gradient, concentrated to approximately
8.52 mg/mL and stored at – 80 °C.
M.4. Characterizing the binding of p10a
4-1 Sedimentation velocity and sedimentation equilibrium
Analytical ultracentrifugation was performed with a Beckman-Coulter XL/I
instrument at 20 °C. Samples were equilibrated into analysis buffer (75 mM NaCl, 20
mM Hepes, 0.1 mM EDTA, pH 7.5) using spin columns. The buffer density was
measured to be 1.0059 g/mL using an Anton Paar DMA-60 density meter. Protein
concentrations were assayed using A280 nm. The following properties were calculated
using Sednterp;

280

in water = 2.980 x 10-3 M-1cm-1, M = 10,252.73, v-bar = 0.7399

g/mL. Standard 2-channel and external-loading, 6-channel centerpieces were used for
sedimentation velocity and equilibrium experiments, respectively. Sedimentation
equilibrium data were fit using non-linear least- squares fitting algorithms with macros
developed in IGOP Pro (Wavemetrics).
4-2 Circular Dichroism Spectroscopy
CD spectra was recorded on a Jasco J-715 spectrometer at 20 °C from 350 to 200
nm with 1 nm spectral bandwidth and 50 nm/min scan rate. CD titration of the 20 base
pair dsRNA with p10a was performed at high RNA concentrations of 7 µM, 10 µM and
20 µM. The dsRNA was made by annealing top and bottom strands and its concentration
was measured by spectroscopy. The sample was loaded into a 2 mm path length quartz
cuvette. Ten scans at 262 nm were averaged for each spectrum. Data were acquired for

the dsRNA alone and following sequential additions from a 126 µM stock of p10a
spectra were corrected for dilution effects, and the intensity data was plotted using
KaleidaGraph.
20mer dsRNA
Bottom strand 20 5’-CGAAGGGCAUGAAGUUCUCC-3’
Top strand 20 3’-GCUUCCCGUACUUCAAGAGG-5’
BS20
Mw = 6405.9 Daltons
Extinction @ 260 nm = 2.26X105 M-1cm-1 (by Excel calculator)
TS20
Mw = 6342.8 Daltons
Extinction @ 260nm = 2.16X105 M-1cm-1
TS20-BS20 duplex
Mw = 12748.7 Daltons
Extinction @ 260 nm = 3.26X105 M-1cm-1 (.739 x T20+B20)
Extinction @ 295 nm = 2.96X104 M-1cm-1 (experimental)
V-bar = .51
(calculated from experimental buoyant weight and known SB4 density)

4-3 Nuclear Magnetic Resonance, NMR
The overall fold of the p10a protein was assayed by NMR spectra. Protein
enriched in 15N was prepared by growing cells minimal media. The MOPS medium was
prepared as the established protocol in Alexandrescu lab and enough 15N p10a protein
was produced for NMR analysis. The procedure was performed by Dr. Alexandrescu in
his laboratory

Recipe of MOPS medium for 300 mL total
260 mL of sterile H2*
70 mL of 5XM buffer
0.7 mL of O solution
0.7 mL of P solution
0.4 mL of S solution
0.4 mL of 0.1% B1 stock
3.5 mL of 40% glucose
20 mM 15N Ammonium Chloride
(*Add

15

N just before induction)

M.5. Characterizing the binding of T16E p10a

5-1 Mutagenesis
a. Primer design and preparation
Introduction of a point mutation at T16E (ACA

GAA), which will change one amino

acid at position 16 in dsRBM I.

T16E p10a coding (above) and non-coding (below) primer design
5'- GCAGGTTTGTCATGGAGGAACTTAATGAATACCGTCAGAAGCAGGG -3'
3'- CGTCCAAACAGTACCTCCTTGAATTACTTATGGCAGTCTTCGTCCC -5'

The concentration of the primers was measured with spectroscopy.
[T16E top] = 630 ng/µL
[T16E bottom] = 823 ng/µL

b. Temperature cycling and Site directed mutagenesis
Site directed mutagenesis was performed using the Quick Change Kit (Stratagene).
The plasmid was denatured and annealed with the oligonucleotide primers containing a
point mutation at T16E. Using the nonstrand-displacing action of PfuTurbo DNA

polynucrease, the mutagenic primers were extended and incorporated, resulting in nicked
circular strands

Reaction mix; The followings were added to the small dome cap micro tube in order;

1) pure water
2) 10X reaction buffer
3) DMSO (4% of total volume)
4) plasmid pET11a-p10a
5) T16E top primer
6) T16E bottom primer
7) dNTPs
Total

Thermocycling Program
segment
1
2

cycle
1
18

3

<Reaction 1>
- 40.7µL
- 5 µL
- 5 µL
- 1.5µL = 127.5 ng
- 1 µL = 630 ng
- 0.8 µL = 658 ng
-1µ
- 49µL

Reaction
melting
melting
annealing
extension
hold

temp(°C)
95
95
55
68
4

<Reaction 2>
- 35.2 µL
- 5 µL
- 5 µL
- 1 µL
- 125 ng
- 131.6 ng
- 1 µL
- 49 µL

time
3 min
30 sec
1 min
14 min
indefinitely

end
*Mixture was heated in segment 1 for 2 min before adding Pfu turbo enzyme

c. Digestion
The completed SDM reaction solution was digested by DpnI restriction enzyme in
order to eliminate methylated and wild-type parent DNA template.

d. Ligation
The digested components were mixed well before adding ligase. The entire
mixture was mixed again, spun down and incubated at 16 °C overnight.

e. Transfer p10a gene
The ligation product was transformed into 50 µL XL1-Blue supercompent cells.
The transformation reactions were swirled gently to mix and incubate the reactions on ice
for 30 min. A heat pulse was applied to the transformation reactions for 45 sec. at 42 °C
by dipping the tube in 42 °C water bath, and then the reaction was placed on ice for 2
min. Appropriate volumes of cells were plated on the LB plates containing carbenicillin
(50 µg/mL). The transformed plates were incubated at 37 °C overnight.

The procedure described in “1-1 Preparation of plasmids” was used to make glycerol
stocks in NovaBlue cells and Rosetta (DE3) plysS cells. The glycerol stocks were stored
at – 80 °C.

Results

1.Cloning the p10a gene into the pET-11a plasmid
The NovaBlue competent cells, that contain the anpicillin resistant pET-11a
plasmid with a p10a gene insertion, produced many colonies on the LB plates containing
50 µg/mL carbenicillin. In contrast, no colonies were observed for the negative control,
the NovaBlue competent cells with kanamycin resistant plasmid pET-28, and with
background plates lacking the insert. This result indicated the success of p10a gene
transfer from the pET-28 plasmid to the pET-11a plasmid. The sequence of the pET-11a
plasmid with p10a gene insertion was confirmed by ABI-Prism sequencing. The glycerol
stocks of pET-11a p10a in NovaBlue and Rosetta cells were stored for later experiments.

2. Optimizing expression of p10a by induction
The cells were grown in LB medium at 37 °C until A600 nm approximately 0.6 and
optimal protein expression was determined to be three-hour induction with 1 mM IPTG
at 37 °C.

Cell Growth at Induction
Time (hr)
0
A600 nm
0.055

1.5
0.021

2.5
0.03

3.5
0.092

4
0.247

5
0.6

It took about four hours to reach 0.3 OD. After reaching to the doubling rate, the cell
growth was exponential. Within one hour it reached to the ideal concentration for
induction.

MES SDS Gel Analysis of Testing Induction (figure 3)

Lane #

1 2 3 4 5 6 7 8 9 10 11 12
m b 3 2 1 0 m b
hour of induction

17 kDa
11 kDa
6 kDa

10 kDa
dsRBM I (p10a)

3 kDa

Lane 1
2
3
4
5
6
7
8
9
10
11
12

empty
empty
empty
MultiMark 5 uL
Bench marker 5 uL
3-hour induction 30 uL
2-hour induction 30 uL
1-hour induction 30 uL
pre-induction 30 uL
MultiMark 5 uL
Bench marker 5 uL
empty

The gel result showed that three-hour induction had the most p10a production compared
to 2hr, 1 hr and pre-induction.

From 500 mL of LB in a 2 L flask, 9.49 mg/Liter of cell paste was protein was harvested.

3 Column Chromatography

(figure 4)

The lysed cells were treated by PEI precipitation and centrifugation. The
supernatant was applied to an S-Sepharose ion exchange column (Amersham)
equilibrated in buffer A and p10a was eluted using a NaCl gradient from 50 mM to 1 M.
The peak fractions were diluted two-fold with buffer A0 (20 mM Bicine, 1 mM EDTA,
5% Glycerol, 10 mM -mercaptoethanol, pH 8) in order to reduce its salt concentration
and applied to a Heparin Sepharose column (Amersham) equilibrated in buffer A. The
p10a protein was eluted using the same NaCl gradient, concentrated to approximately
8.52 mg/mL and stored at – 80 °C.

S Sepharose ion exchange column
fraction #46 - #36, #41,#47 and #57
were analyzed by the SDS gel

Heparin Sepharose affinity column
fraction #24 - #34 were analyzed by
the SDS gel

SDS Gel Analysis of S-Sepharose Protein Purification (Figure 5)
Lane#

13 12 11 10 9 8 7 6 5 4 3 2
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.

P10a

Lane#

P10a

2

3 4 5 6 7

8 9 10 11 12 13

empty
marker
fraction #14
fraction #16
fraction #18
fraction #20
fraction #22
fraction #24
fraction #26
flow through
PEI precipitate
PEI supernatant
marker
empty
empty

1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.

empty
marker
fraction #28
fraction #30
fraction #32
fraction #34
fraction #36
fraction #41
fraction #47
fraction #57
flow through
PEI supernatant
marker
empty
empty

These gels were dried instead of being scanned. The lane 9-5 of upper gel, and lane 3
and 4 of bottom gel are demonstrating fairly well purified p10a protein.

SDS Gel Analysis of Heparin Sepharose Column Protein Purification (Figure 6)

Lane#

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

p10a

Lane

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15

marker, 5uL
fraction # 24, 20 µL
fraction # 25, 20 µL
fraction # 26, 20 µL
fraction # 27, 20 µL
fraction # 28, 20 µL
fraction # 29, 20 µL
fraction # 30, 20 µL
fraction # 31, 20 µL
fraction # 32, 20 µL
fraction # 33, 20 µL
fraction # 34, 20 µL
flow through 20 µL
starting material 20 µL
fraction # 15 (contaminant), 20 µL

The heparin Sepharose column was able to complete the purification process of p10a to
produce pure p10a.

4. Characterizing the oligomeric state of p10a (Figure 7)

4-1 Sedimentation Velocity
1

2. C(S)

Single large
feature indicates
a monomeric
P10a

Small feature can be
just an artifact

1. An initially uniform solution of p10a with buffer was placed in the cell and high angular
velocity was used (55,000K) to cause rapid sedimentation of p10a toward the cell bottom. The
boundary between depleted p10a concentration region near the meniscus and its sedimenting
region was analyzed. The only one sharp sedimenting boundary indicates uniform concentration
of solution and it suggests the homogeneity of solution, therefore, p10a is a monomer. 2. The
single large feature at 1.2S of the C(S) graph indicates a monomeric p10a. And a small feature at
3.5S can be interpreted in three possible ways. 1) The p10a exists mostly monomeric state, and a
small portion of dimer and the interconversion between monomer and dimer is slow (two peaks
are separated), 2) A small amount of aggregation was observed, or 3) It is also possible that it is
just an artifact.

S V o f th e d s R B M 1 ;
C o n c e n tra tio n D e p e n d e n c e

Figure 8
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The sedimentation coefficient decreased slightly as protein concentration increased. The
slight decrease in S with concentration is due to the hydrodynamic non-ideality. There is
no self-association. The calculated sedimentation constant at zero concentration at 20 °C
in water was 1.23 and its friction coefficient was 3.575 H 10-8. Therefore, the frictional
ratio is 1.30. The dsRBM I must be non-globular and have more asymmetric shape.
S°20,W = S°(1-v

20,W)

20,B

/ (1- v

20,B)

20,W,,

S° = (1.23){(1 - .7409 H.9982)(1.01H10-2) / (1-.7409H1.00359)(1.002H10-2)} = 1.23

Ro = (3Mv / 4 NA)1/3 , Ro = {(3H10165.65H.7409) / (4 H6.022X1023)}1/3 = 1.44H10-7
f°=6

20,BR°,

fP = M(1- v

f° = 6 (1.01H10-2)(1.44H10-7) = 2.14H10-8

20,B)

/ NA S°(1H10-13), fP = {10165.65H(1-.7049H.9982)} / (6.022H1023)H1.23(1H10-13) = 3.575H
H10-8

fP / f ° = (3.575H10-8) / (2.741H10-8) = 1.30

4-2 RNA Binding Stoichiometry (Figure 9)
p10a Stoichiometry Comparison:
RNA 1um vs 6uM
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This graph shows two titration of a 20 base pair dsRNA with the dsRBM I (p10a).
It was monitored by sedimentation equilibrium at 260 nm and 30,000 rpm. Under these
conditions, the absorption contribution from the protein is negligible relative to the RNA
because the extinction coefficient of RNA (
extinction coefficient of p10a protein (

RNA, 260nm)

protein, 260 nm).

is 50 times more then the

Therefore, as the number of protein

that bound to dsRNA increases, the buoyant mass of the RNA also increases. The signalaverage buoyant mass of the RNA in the absence of protein was 5385 in the 2nd
experiment and 6930 in the 3rd experiment (theoretically 5944). The calculated buoyant
mass of p10a is 2590 in analysis buffer. Over a protein concentration range of 0 to7 µM
(#2) and 0 to 70 µM, M260 increased to approximately 9454. However, it did not reach to
saturation. Therefore, it was not possible to determine its stoichiometry. It is probability
due to a weak binding of p10a.

4-3 Nuclear Magnetic Resonance (NMR) (figure 10)

15

N

1

H

The overall folding of the p10a protein was assayed by NMR spectra. Protein enriched in
15

N was prepared growing cells in minimal medium containing 15N-NH4Cl as the labeled

nitrogen source. The medium was prepared using and established protocol in
Alexandrescu lab and enough 15N p10a protein was produced for NMR analysis. In the
spectrum (figure 13), the blue peaks are from dsRBD (p20) and yellow peaks are from
dsRBM I (p10a). Since the yellow signals are at approximately the same position as blue
signals (protein size and/or pH differences causes slight shifts) the overall folding of
dsRBM I in p10a and p20 are the same.

4-4 Circular Dichroism Spectroscopy (Figure 11)
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CD spectroscopy was also performed in order to determine the binding
stoichiometry. In crystal structure of a related dsRBM, binding of the protein to dsRNA
caused slight the unwinding the double helix (Ryter et al., 1998) and the ellipticity near
260 nm is linearly related to the helical winding angle (Bloomfield et al., 2000). Figure
10 shows a CD titration of the 20 base pair dsRNA with dsRBM I (p10a). It was
performed at high RNA concentration (20 µM). Because these data show no saturation,
the stoichiometry of p10a - 20mer dsRNA could not be determined.

5. Characterizing the binding of T16E p10a to a dsRNA
5-1 Mutagenesis - T16Ep10a
Through a search of the published sequence alignment of numerous dsRBMs of
dsRNA binding proteins, the conserved sequences among the dsRBMs were found. A
hypothesis was suggested that a mutation from threonine (polar) to glutamate (negatively
charged) at position 16, which is consensus among many dsRBM include RNase III,
would strengthen the bindings of p10a to dsRNA. Therefore, the introduction of a point
mutation at T16E (ACA to GAA) was prepared.
The introduction of a point mutation was completed successfully. The
transformation and digestion of the DNA went well. The numbers of colony on the plate
were the following;

+ DpnI
- DpnI

50 µL
150 µL
250 µL
150 µL

Reaction 1
6
20
10
TNTC

Reaction 2
6
44
45
TNTC

In order to confirm its sequence, ABI-Prism sequencing was performed and confirmed

5-2 Sedimentation equilibrium
The following two RNA binding stoichiometry graphs (Figure 12 and 13) show
the result of several sedimentation equilibrium experiments of p10a-dsRNA binding
under different conditions. In order to find its stoichiometry, several experiments were
performed as trial and error to observe the saturation of their binding. The RNA binding
stoichiometry I (Figure 12) is a graph of the binding comparison between mutant p10a
T16E and wild type p10a to 1 µM and 20bp of dsRNA at 75 mM NaCl salt concentration.

Because p10a did not bind to dsRNA tightly, the saturation point was not observed.
Therefore, salt concentration was lowered so that salts will not interact with the binding
site of protein and RNA, hoping to create a better protein-RNA binding environment.
The RNA binding stoichiometry II (Figure 12) shows the binding of p10a T16E to 1 µM
and 20bp of dsRNA under the low salt concentration (10 mM NaCl). In order to observe
the saturation, the second experiment was extended to the higher ratio of p10a T16E over
RNA.
A mutation of threonine to glutamate was introduced at position 16 and the
mutated p10a was set to bind to 20bp dsRNA under the low salt concentration. By
combining the two changes (point mutation and salt concentration), the isolated p10a
binding to dsRNA was observed up to saturation. This result supports the previously
generated data three to one stoichiometry of dsRBD-dsRNA (Ucci, 2004). The modified
salt condition is not the same as physiological condition; however, it is worth finding the
binding stoichiometry and other character of binding mechanisms of PKR’s motif.

RNA Binding Stoichiometry I

(figure 12)
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Sedimentation equilibrium was performed several times after the introduction of T16E
mutation. If the mutation of one amino acid was significant enough to make protein’s
binding to dsRNA tighter, the graph should reach to saturation under such high dsRNA
concentration. Figure 11 shows two titration of the 20bp dsRNA by wild type of dsRBM
I (p10a WT, blue) and mutated dsRBM I (p10a T16E, red). In the comparison of these
two motifs, M260 curves were similar and indicating the increase of binding of p10a to
dsRNA. However, the buoyant molecule weight did not reach to the point of saturation.
The mutationT16E alone did not help to bring their binding to saturation. Thus, the
stoichiometry could not be determined

RNA Binding Stoichiometry II (Figure 13)
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The sedimentation equilibrium data above shows saturation with three T16E p10a
proteins bound to 20mer dsRNA under the low salt condition (10 mM NaCl). The
mutation of T16E alone was not enough to make tighter binding of p10a to reach proteindsRNA binding saturation. However, by lowering salt concentration to enhance binding
of p10a to dsRNA, saturation was observed. In the first experiment, the p10a
concentration was not high enough and saturation was not observed. Thus, for the second
experiment, p10a the final concentration was increased from 8 µM to 17 µM and we were
able to see a saturation point. This result of three to four dsRBM I binding to 20bp
dsRNA agrees with Cole lab’s stoichiometry result of dsRBD 20bp dsRNA (Ucci et al.,
2004).

Discussion

The dsRBMs play a key role in PKR function and regulation. Despite extensive
investigation, their exact role in PKR activation is still not well understood. A detailed
understanding of the mechanism of PKR activation is necessary to effectively target this
enzyme for clinical intervention against cancer and viral infections. PKR is one of the
most studied dsRNA binding proteins and I studied dsRBM I, one of the dsRBMs at the
N terminus of PKR using biophysical approaches. A method of p10a expression in its
native form was established as well as its purification method. My study of its binding
characterization has produced fascinating results, which may overturn established theory.
Further investigation on the subject will be necessary to confirm the findings.

1. p10a expression
A plasmid containing the dsRBM I gene (p10a) was received from Michael B.
Mathews (New Jersey Medical School). The gene was in the pET-28 vector, containing
an N-terminal polyhistidine tags, therefore, the gene needed to be transferred to pET-11a,
non-histidine tag plasmid. These “tags” are fused to facilitate detection and purification
of the target protein. However, the positively charged histidine tags may alter the
structure and function of proteins. Thus, the native protein without tags was required in
my research. The established protocol for purification of this protein was
straightforward, only two columns were used and enough pure protein was harvested
after the purification. Therefore, histidine tags are unnecessary.

The cloning and expressing of recombinant proteins in E. coli were performed
using pET vectors (Novagen). Target genes were cloned in pET plasmids under control
of strong bacteriophage T7 transcription, and expression was induced by providing a
source of T7 RNA polymerase in the host cell. When the plasmid is transferred into an
expression host containing a chromosomal copy of the T7 RNA polymerase gene under
lacUV5 control, the target protein was expressed upon the addition of IPTG to the
bacterial culture. The design of pET vectors worked favorably with p10a gene, and high
yield protein was harvested with a three-hour induction.
Transferring of p10a gene from pET-28 to pET-11a was attempted by two
methods. One of the methods was double digestion of plasmids. Both plasmids, pET-28
with p10a gene and pET-11a, were first digested by the restriction enzymes, NdeI and
BamHI. After digestion, the complementary ends of the digested DNA fragments were
annealed, and sealed by treatment with DNA ligase. Because the selectable marker
included on the vector was anmicillin resistance, only pET-11a containing the p10a gene
was selected. Synthesis of the dsRBM I expression plasmid by site directed mutagenesis
was performed as alternative method. A stop codon was inserted in the linker region
between p10a (dsRBM I) and p10b (dsRBM II) using pET-11a-p20 made in Cole lab.
Mutagenic primers were designed and the desired DNA was synthesized using the QuikChange kit (Stratagene). In order to eliminate the methylated and non-mutated parent a
DNA template, the PCR product was digested by DpnI. Since stop codon stops
translation, only the p10a protein should be expressed.
Theoretically, both methods are feasible and wild type p10a protein was expected
to be harvested. However, this stage was very time consuming and challenging. One of

the factors contributed to this difficulty could be the size of the protein. The p10a is a
very small protein, it consists of only 91 amino acids, and therefore to recover this DNA
from the gel was technically very difficult. After many trials, the double digestion and
cloning method produced the p10a gene in a pET-11a vector. The product was
transferred into XL1-Blue Supercompetent Cells.
Induction was tested by visualizing p10a expression with SDS-PAGE of whole
cell lysate. A study of the time-course indicated that a three-hour induction yielded the
maximum p10a protein (figure 3). Thus, three-hour induction was performed on a large
scale in order to synthesize large quantity of p10a protein.

2. The p10a purification
The p10a protein purification method was adapted from a published p20
purification method (Ucci and Cole, 2004) with slight modifications. The buffer pH was
decreased from pH 8.65 to pH 8.00, and the final sephacyl S-100 gel filtration was
eliminated. At first, cell lysis was performed on cells suspended in buffer by sonication
and PEI precipitation was performed in order to remove nucleic acid Protein in the
supernatant was purified through a S-Sepharose ion exchange column followed by a
Heparin Sepharose affinity column. The fractions monitored during S-Sepharose column
purification showed a single large UV peak, indicating p10a protein elution, and a few
UV peaks of contaminant (figure 4). The fractions of the p10a elution were visualized by
the gel analysis and confirmed to be fairly purified protein with only few contaminants
(figure 5). The p10a was diluted two-fold with buffer in order to reduce salt

concentration and was further purified through a Heparin Sepharose column equilibrated
in buffer A. The p10a protein eluted at 250 mM NaCl without any contaminant (figure
6); therefore, this process resulted in p10a protein purification. The establishment of this
purification method was straightforward and fewer steps were required. NMR was
utilized to confirm folding of the isolated dsRBM I. Since protein folding is very
important for protein’s function, the confirmation of protein folding was important. The
NMR indicated that the overall folding of both dsRBD (p20) and dsRBM I (p10a) were
the same by overlapping signals of both proteins.

3. The P10a binding to dsRNA characteristics
Analytical ultracentrifugation is a useful tool for the detailed characterization of
protein and for understanding the stoichiometry of protein-RNA interaction in free
solution. Since PKR-RNA binding may have non-specific interactions, which generally
have lower affinity and higher dissociation rates than specific interactions, it is
particularly susceptible to artifacts associated with dissociation during the measurement.
Solution equilibria may be defined by the gel shift and filter-binding assays under
carefully controlled conditions; however, to achieve correct solution equilibria is
meticulous process due to low affinity and high dissociation rates. Analytical
ultracentrifugation provides more accurate characterization of dsRBM I-RNA interaction.
The Cole lab has adapted a model for non-specific protein-RNA interaction for global
fitting of multiwavelength sedimentation equilibrium analysis (Ucci and Cole, 2004).
For the study of the mechanism of activation PKR by RNA binding, it is important to
understand the interaction thermodynamics of various PKR domains with a structurally

defined dsRNA sequence. The multiwavelength sedimentation equilibrium is a practical
method to characterize the stoichiometry and affinity of protein –nucleic acid
interactions. The sedimentation equilibrium study does not require labeling of the
reagents and uses fairly small amounts of material and measures the sequential binding of
each protein ligand to the lattice. Thus, the relationship between sequential binding
constants can be determined.
The sedimentation velocity was the first analysis performed in characterization of
p10a protein. In sedimentation velocity experiment, a buffer diluted p10a sample, which
was initially uniformly distributed, was placed in the cell and high angular velocity was
used to cause relatively rapid sedimentation of p10a towards the cell bottom. As p10a
was sedimenting towards the cell bottom, an evidence of homogeneity was observed by a
single boundary. This result suggested that p10a protein existed as monomer in a free
solution. In addition, C (S) analysis showed a single large feature at 1.2S, which
indicated monomeric p10a. There was a very small feature at 3.0S, which may be
explained by the presence of a small amount of dimeric p10a with a very slow
interconversion rate. However, it was probably not the case because the sedimentation
coefficient of 3.0S is too high to a dimer relative to the monomer peak at 1.2S. The
dimer peak should appear about 1.5 times of the monomer peak. It may also be explained
by the presence of very small amount of aggregate, or it can be just an artifact.
Numerous studies have demonstrated dimerization of isolated binding motifs. Published
data suggest that both dsRBMs have an intrinsic ability to dimerize (dsRBM II) or
multimerize (dsRBM I) (Tian and Mathews, 2000). In contrast, my data indicated a
monomeric state of dsRBM I in free solution and it contradicts the published data.

Further investigation is required to confirm my observation. The calculated
sedimentation coefficient at zero concentration at 20°C in water was; S°20,W = 1.23. The
frictional coefficient of a smooth sphere model with the same molecular weight and
specific volume of p10a is; f° = 2.741 x 10-8. And measured friction coefficient of p10a
was; fp10a = 3.575 H 10-8. Therefore, fractional ratio fp10a / f° was 1.30, indicating nonglobular and asymmetric shape of p10a.
Sedimentation Equilibrium was also performed in order to characterize dsRBM IdsRNA interaction. This experiment was a measurement of the increase in the buoyant
mass of dsRNA up to saturation. If dsRBM I (p10a protein)-dsRNA interaction had
reaches saturation, its stoichiometry could have been determined. However, to set
conditions so that the interaction would reach saturation was difficult due to a very weak
affinity of isolated p10a protein. A set of sedimentation equilibrium experiments was
performed at dsRNA and p10a concentration. Regardless of my effort, wild type p10a
did not bind tight enough to reach saturation. Therefore, mutations were introduced to
control the protein-dsRNA binding strength by altering its amino acid side chain, T16E.
This mutation was designed by locating conserved amino acids among tight binding
dsRBMs. However, this mutation did not show any change in their affinity. An
additional modification, lowering salt condition, was applied. Finally, protein-dsRNA
binding reached saturation by introducing both modifications, thus its stoichiometry was
determined as three or four to one (figure 12). This stoichiometry is the same as p20 and
suggests that only dsRBM I binds to dsRNA. Therefore, a new overlapping lattice model
of dsRBD-RNA binding, which Cole lab had introduced, was supported by my data as
well.

Circular dichroism spectroscopy was also attempted to generate supporting data.
To balance the protein and dsRNA concentration in order to obtain saturation was again a
problem in this experiment. Despite several experiments by varying each concentration,
the stoichiometry was not able to be determined yet. If the CD data agrees with the
stoichiometry of protein-dsRNA interaction from the sedimentation results, it would be a
very strong evidence to support the Cole lab’s new overlapping lattice model.

References
1. Bloomfield, V.A, Crothers, D.M., Tinocco, I. (2000) Nucleic Acids: structures,
properties and functions. University Science Books.
2. Carlson, C. B., Stephens, O. M. and Beal P. A. (2003) Recognition of DoubleStranded RNA by Proteins and Small Molecules. Biopolymers 70, 86-102.
3. Conrad, C, Evguenieva-Hackenberg, E, Klug, G. (2001) Both N-terminal catalytic
and C-terminal RNA binding domain contribute to substrate specificity and
cleavage site selection of RNase III FEBS Lett 509,53-58.
4. Fierro-Monti, I.and Mathews, M. B. (2000) Proteins binding to duplexed RNA:
one motif, multiple functions. Trends Biochem. 25, 241-246.
5. Gale, M., Jr., and Katze, M. G. (1998) Molecular mechanisms of interfereon
resistance mediated by viral-directed inhibition of PKR, the interferon-induced
protein kinase. Pharmacol., 78, 29-46
5. Joklik, Wolfgang, et al. (1998) Zinsser Microbiology 19th ed.
6. Lemaire, P. A., Lary, J., Cole, J. L. (2005) Mechanism of PKR Activation:
Dimerization and Kinase Activation in the Absence of Double-stranded RNA. J.
Mol. Biol. 345, 81-90
7. Patel, R. C, Stanton, P. and Sen, G. C. (1996) Specific mutations near the amino
terminus of double-stranded RNA-dependent protein kinase (PKR) differentially
affect its double-stranded RNA binding and dimerization properties. J. Biol.
Chem. 271, 25657-25663.
8. Ryter, J. M., Schultz S. C. (1998) Molecular basis of double-stranded RNAprotein interactions: structure of a dsRNA-binding domain complex with dsRNA.
EMBO J. 17, 7505-7513.
9. Schmedt, C., Green, S. R., Manche, L., Taylor, D. R., Ma, Y., Mathews, M. B.
(1955) Functional Characterization of the RNA-binding Domain and Motif of the
Double-stranded RNA-dependent Protein Kinase DAI(PKR) J. Biol. Chem. 249,
29-44
10. Spanggord, R. J., Vuyisich, Momchilo., Beal., P. A., (2002) Identification of
Binding Sites for Both dsRBMs of PKR on Kinase-Activation and KinaseInhibiting RNA Ligands. J. Biol. Chem. 41, 4511-4520.
11. Stark, G. R., Kerr, I. M., Williams, B. R., Silverman, R. H., Schreiber, R. D.
(1998) How cells respond to interferons. Annu, Rev. Biochem. 67, 227-264
12. Tian, B. and Mathews, M. B. (2001) Functional Characterization of and
Cooperation between the Double-stranded RNA-binding Motifs of the Protein
Kinase PKR. J. Biol. Chem. 13, 9936-9944.
13. Ucci, J. W., Cole, M. L. (2004) Global analysis of non-specific protein-nucleic
interactions by sedimentation equilibrium. Biophysical Chem. 108, 127-140.

Research Advisor:
Dr. James L. Cole

Honors Advisor:
Dr. Lawrence Hightower

